| Primary |
| Postoperative Care |
24.9% |
| Product Used For Unknown Indication |
13.1% |
| Drug Use For Unknown Indication |
10.9% |
| Cataract Operation |
9.0% |
| Glaucoma |
5.9% |
| Dry Eye |
4.1% |
| Eye Inflammation |
4.1% |
| Iritis |
3.2% |
| Inflammation |
2.7% |
| Uveitis |
2.7% |
| Cataract |
2.3% |
| Corneal Transplant |
2.3% |
| Ocular Hyperaemia |
2.3% |
| Ulcerative Keratitis |
2.3% |
| Attention Deficit/hyperactivity Disorder |
1.8% |
| Eye Infection |
1.8% |
| Eye Lubrication Therapy |
1.8% |
| Retinopathy |
1.8% |
| Rheumatoid Arthritis |
1.8% |
| Corneal Oedema |
1.4% |
|
| Vision Blurred |
11.1% |
| Visual Acuity Reduced |
11.1% |
| Intraocular Pressure Increased |
9.9% |
| Ocular Hyperaemia |
7.4% |
| Blood Glucose Increased |
4.9% |
| Cataract |
4.9% |
| Drug Ineffective |
4.9% |
| Dysgeusia |
4.9% |
| Eye Pain |
4.9% |
| Dyspnoea |
3.7% |
| Eye Irritation |
3.7% |
| Iritis |
3.7% |
| Off Label Use |
3.7% |
| Product Substitution Issue |
3.7% |
| Pruritus |
3.7% |
| Psychotic Disorder |
3.7% |
| Conjunctivitis |
2.5% |
| Corneal Opacity |
2.5% |
| Cough |
2.5% |
| Drug Effect Decreased |
2.5% |
|
| Secondary |
| Postoperative Care |
23.1% |
| Drug Use For Unknown Indication |
9.0% |
| Eye Oedema |
8.6% |
| Product Used For Unknown Indication |
8.6% |
| Attention Deficit/hyperactivity Disorder |
6.7% |
| Blood Cholesterol Increased |
6.2% |
| Autism |
5.7% |
| Glaucoma |
4.5% |
| Dry Eye |
4.0% |
| Cataract Operation |
3.6% |
| Polyarthritis |
3.1% |
| Oedema |
2.6% |
| Hypertension |
2.1% |
| Atrial Fibrillation |
1.9% |
| Eye Inflammation |
1.9% |
| Supplementation Therapy |
1.9% |
| Type 1 Diabetes Mellitus |
1.9% |
| Gastrooesophageal Reflux Disease |
1.7% |
| Eye Injury |
1.4% |
| Ocular Hypertension |
1.4% |
|
| Visual Acuity Reduced |
15.3% |
| Vision Blurred |
11.8% |
| Eye Swelling |
10.6% |
| Drug Ineffective |
5.9% |
| Blood Glucose Increased |
4.7% |
| Corneal Opacity |
4.7% |
| Diarrhoea |
4.7% |
| Intraocular Pressure Increased |
4.7% |
| Petechiae |
4.7% |
| Eye Irritation |
3.5% |
| Ocular Hyperaemia |
3.5% |
| Psychotic Disorder |
3.5% |
| Swelling Face |
3.5% |
| Visual Impairment |
3.5% |
| Weight Decreased |
3.5% |
| Cataract |
2.4% |
| Conjunctivitis |
2.4% |
| Eye Pruritus |
2.4% |
| Headache |
2.4% |
| Idiosyncratic Drug Reaction |
2.4% |
|
| Concomitant |
| Product Used For Unknown Indication |
25.2% |
| Drug Use For Unknown Indication |
11.9% |
| Uveitis |
10.0% |
| Acute Myeloid Leukaemia |
5.9% |
| Postoperative Care |
5.5% |
| Pain |
5.3% |
| Hypertension |
4.5% |
| Glaucoma |
3.8% |
| Prophylaxis |
3.7% |
| Ankylosing Spondylitis |
3.1% |
| Menopausal Symptoms |
2.6% |
| Rheumatoid Arthritis |
2.6% |
| Acne |
2.3% |
| Photorefractive Keratectomy |
2.3% |
| Inflammation |
2.1% |
| Antiinflammatory Therapy |
2.0% |
| Asthma |
1.9% |
| Depression |
1.9% |
| Off Label Use |
1.8% |
| Vitamin Supplementation |
1.7% |
|
| Visual Acuity Reduced |
14.6% |
| Demyelination |
9.0% |
| Impaired Healing |
7.0% |
| Stomatitis |
6.0% |
| Uveitis |
6.0% |
| Eye Irritation |
5.5% |
| Corneal Disorder |
4.5% |
| Pneumonia |
4.5% |
| Postoperative Wound Complication |
4.5% |
| Vision Blurred |
4.5% |
| Sepsis |
4.0% |
| Visual Impairment |
4.0% |
| Endophthalmitis |
3.5% |
| Vitreous Floaters |
3.5% |
| White Blood Cell Count Decreased |
3.5% |
| Corneal Opacity |
3.0% |
| Injection Site Pain |
3.0% |
| Post Procedural Complication |
3.0% |
| Punctate Keratitis |
3.0% |
| Retinal Detachment |
3.0% |
|
